RxDoctor Payments Data

Shera Aranoff, MD

Procedural Dermatology · New York, NYNPI 1538139373

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 457 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 25.7% of the total.

$7,576in general payments, 2019–2025

Across 457 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
  • Johnson & Johnson$589
  • Sun Pharmaceutical Industries Inc.$564
  • UCB, Inc.$416
  • Lilly USA, LLC$376
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$7,45198%
  • Education$1262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,576 in reported general payments places this provider in the 60th percentile of 69 procedural dermatology providers in New York.

See all procedural dermatology providers in New York

Medicare billing

Part B allowed, 2024
$191,588
Medicare patients
553
Services billed
1,571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$44,476
Clobetasol Propionate104$5,354
Fluorouracil41$1,859
ValacyclovirValacyclovir Hcl29$1,561
Mupirocin83$606
Triamcinolone Acetonide37$401
Minoxidil21$350
Cephalexin11$255
Propranolol Hcl18$241
Nortriptyline Hcl22$223
Fluconazole11$156

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →